Research Article
Risk Factors and Scoring System for Predicting Bacterial Resistance to Cefepime as Used Empirically in Haematology Wards
Table 2
Microbial documentation of the 103 first episodes of bacteraemia in haematology patients and resistance to cefepime.
| | | Number (%) | Number (%) resistant to cefepime |
| | Gram-positive cocci | 65 (63) | 37 (57) | | Staphylococci | | | | Staphylococcus aureus | 7 | 0 (0) | | Coagulase negative staphylococci | 28 | 25 (89) | | Streptococci and enterococci | | | | Oral streptococci | 14 | 0 (0) | | Enterococcia | 11 | 11 (100) | | Other Gram-positive | 5 | 1 (20) | | Gram-negative bacteria | 38 (37) | 13 (34) | | Enterobacteriaeb | 21 | 8 (38) | | Pseudomonas aeruginosa | 4 | 1 (25) | | Acinetobacter sp. | 6 | 1 (17) | | Nonaeruginosa pseudomonas | 3 | 0 (0) | | Stenotrophomonas sp. | 3 | 3 (100) | | Leptotrichia buccalis | 1 | 0 (0) |
| | Total | 103 | 50 (49%) |
|
|
None enterococci was resistant to vancomycin.
Includes 3 ESBL-producing Enterobacteriaceae and 1 carbapenemase-producing E coli.
|
